Ginkgo Biloba Preparations: Toward Discoveries in the Clinical Neuropharmacology
DOI:
https://doi.org/10.22141/2224-0713.4.82.2016.77708Keywords:
ginkgo extract, mechanism of action, Bilobil, Bilobil IntensAbstract
The most relevant and current data on the basic mechanisms of action of ginkgo biloba extract are presented in the article: neurotransmitter effects, neurometabolic effects, vasotropic effects. Popularity of gingko biloba extract in neurology is related to its efficiency and safety.Downloads
References
Арушанян Э.Б., Бейер Э.В. Ноотропные свойства препаратов гинкго билоба // Эксп. клин. фармакол. — 2008. — Т. 71, № 4. — С. 57-63.
Астахова А.В. Побочные эффекты компонентов БАД. Предостережения в отношении их использования в пред- и послеоперационном периодах // Безопасность лекарств. Экспресс-информация. — 2002. — С. 16-23.
Бурчинский С.Г. Вазотропная фармакотерапия: новые аспекты // Журн. практ. лікаря. — 2001. — № 6. — С. 57-60.
Бурчинский С.Г. Возможности препаратов гинкго в стратегии фармакотерапии сосудистой деменции // Міжнар. неврол. журн. — 2015. — № 6. — С. 131-136.
Камчатнов П.Р. Возможности применения экстракта гинкго билоба в неврологической практике // Журн. неврол. психиат. — 2010. — Т. 110, № 5. — С. 51-56.
Кузнецова С.М., Шульженко Д.В. Экстракт гинкго билоба в стратегии лечения хронических сосудистых заболеваний головного мозга // Міжнар. неврол. журн. — 2015. — № 2. — С. 109-115.
Мищенко Т.С., Мищенко В.Н., Лапшина И.А. Билобил Интенс в лечении больных с дисциркуляторной энцефалопатией, обусловленной атеросклерозом и артериальной гипертензией // Міжнар. неврол. журн. — 2012. — № 6. — С. 9-14.
Старение мозга / Под ред. В.В. Фролькиса. — Л.: Наука, 1991. — 277 с.
Штрыголь С.Ю., Кортунова Т.В., Штрыголь Д.В. Побочные эффекты ноотропных средств // Провизор. — 2003. — № 11. — http.//www.provisor.com.ua.
Ahlemeyer B., Krieglstein J. Neuroprotective effects of ginkgo biloba extract // Cell. Mol. Life Sci. — 2003. — V. 60. — P. 1779-1792.
Chan P.C., Xin Q., Fu P.P. Ginkgo biloba leave extract: biological, medicinal and toxicological effects // J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. — 2007. — V. 25. — P. 211-244.
DeFeudis F.V., Drieu K. Ginkgo biloba extract (Egb 761) and CNS functions: basic studies and clinical applications // Curr. Drug Targets. — 2000. — V. 1. — P. 25-58.
Doody R.S., Stevens J.C., Beck C. et al. Practice parameter: management of dementia (an evidence-based review) // Neurology. — 2001. — V. 56. — P. 1154-1166.
Eckert A., Koil U., Kressmann S. et al. Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress // Pharmacopsychiatry. — 2003. — V. 36, suppl. 1. — P. 15-23.
Erdenek P. Vasoactive agents in cerebrovascular pathology // Mag. Clin. Rev. — 2012. — V. 11. — P. 84-93.
He Y.T., Xing S.S., Gao L. et al. Ginkgo biloba attenuates oxidative DNA damage of human umbilical vein endothelial cells induced by intermittent high glucose // Pharmazie. — 2014. — V. 69. — P. 203-207.
Huquet F., Drieu K., Piriou K. Decreased cerebral 5-HT 1a receptors during aging: reversal by Ginkgo biloba extract (Egb 761) // J. Pharm. Pharmacol — 1994. — V. 46. — P. 316-318.
Koch E. Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts // Phytomedicine. — 2005. — V. 12. — P. 10-16.
Kristofikova Z., Benesova O., Tejkalova H. Changes of high-affinity choline uptake in the hippocampus of old rats after long-term administration of two nootropic drugs (Tacrine and Ginkgo biloba extract) // Dementia. — 1992. — V. 3. — P. 304-307.
Li X.X., Chen S.X., Ye G.S. et al. Protective effects of extract of ginkgo biloba on vascular endothelial dysfunction induced by AGEs-BSA in vivo // Zhong Yao Cai. — 2007. — V. 30. — P. 1109-1113.
Luo Y. Alzheimer’s disease, the nematode Caenorhabditis elegans, and ginkgo biloba leaf extract // Life Sci. — 2006. — V. 78. — P. 2066-2072.
Marks I.E. Cure and care of neurosis. — N.Y.: J.V. Scott Med. Found., 2001. — 429 p.
Mehta M.A., Riedel W.J. Dopaminergic enhancement of cognitive function // Curr. Pharm. Des. — 2006. — V. 12. — P. 2487-2500.
Pardon M.C., Joubert C., Perz-Diaz F. et al. In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extract (EGb 761) // Mech. Ageing Dev. — 2000. — V. 113. — P. 157-168.
Rojas P., Ruiz-Sanchez E., Rojas C. et al. Ginkgo biloba extract (Egb 761) modulates the expression of dopamine-related genes in 1-methyl‑4-phenyl‑1,2,3,6-tetrahydropyridine-induced parkinsonism in mice // Neuroscience. — 2012. — V. 223. — P. 246-257.
Sastre J., Lloret A., Borras C. et al. Ginkgo biloba extract EGb 761 protects against mitochondrial aging in the rat brain and in the liver // Cell. Mol. Biol. — 2002. — V. 48. — P. 685-692.
Schneider L.S., DeKosky S.T., Farlow M.R. et al. A randomized, double-blind, placebo-controlled trial of two doses of ginkgo biloba extract in dementia of the Alzheimer’s type // Curr. Alzheimer’s Res. — 2005. — V. 2. — P. 541-551.
Shah Z.A., Sharma P., Vohora S.B. Ginkgo biloba normalizes stress-elevated alterations in brain catecholamines, serotonine and plasma corticosterone levels // Eur. Neuropsychopharmacol. — 2003. — V. 13. — P. 321-325.
Stark M., Behl C. The ginkgo biloba extract Egb 761 modulates proteasome activity and polyglutamine protein aggregation // Evidence-Based Complement. Alternat. Med. — 2014. — ID940186. — 14 p.
Stoll S., Scheuer K., Pohl O. et al. Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse // Pharmacopsychiatry. — 1996. — V. 29. — P. 144-149.
Sun B., Hu Y., Yuan H. et al. Extract of Ginkgo biloba promotes the expression of VEGF followed subarachnoid hemorrhage in rats // Int. J. Neurosci. — 2009. — V. 119. — P. 995-1005.
Terry A.V., Buccafusco J.J. The cholinergic hypothesis of age- and Alzheimer’s disease-related cognitive deficit: recent challenges and their implications for novel drug development // J. Pharmacol. Exp. Ther. — 2003. — V. 306. — P. 821-827.
Wan W., Cao L., Liu L. et al. Egb 761 provides a protective effect against Abeta1-42 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial model // Plos One. — 2014. — ID0113126.
Watanabe C.M.H., Wolffram S., Ader P. et al. The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba // PNAS. — 2001. — V. 98. — P. 6577-6580.
Yoshitake T., Yoshitake S., Kehr J. The ginkgo biloba extract Egb 761 and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex // Brit. J. Pharmacol. — 2010. — V. 159. — P. 659-668.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 S.H. Burchynskyi
This work is licensed under a Creative Commons Attribution 4.0 International License.